ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 596 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 596; 2) Community: the network communities that were significantly associated with the response to NSC 596; 3) Molecule: the relationships between components within communities and NSC 596; 4) MDR: the compounds that were significantly associated with the NSC 596.

NSC Compound Enrichment Correlation
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0162638908166157 0.59293176
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0162638908166157 -0.24188243
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.0162638908166157 0.084544732
NSC 363979 Cephalostatin 1 0.0162638908166157 0.16629085
NSC 38087 Null 0.0162638908166157 0.69331214
NSC 38090 Null 0.0162638908166157 0.6989066
NSC 621326 Null 0.0162638908166157 0.19433696
NSC 628561 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-dibutyl- 0.0162638908166157 0.33846041
NSC 671175 Null 0.0162638908166157 0.12436931
NSC 673841 1H-Dipyrazolo[1,5-a:4',3'-e]pyrimidine-3,4,7-triamine, 6-[(4-bromophenyl)azo]- 0.0162638908166157 0.11517375
Total:84  Current:26    [First] [Prev] [Next] [Last]